NM_000767.5:c.415A>G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_000767.5(CYP2B6):​c.415A>G​(p.Lys139Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00384 in 1,614,004 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0040 ( 20 hom. )

Consequence

CYP2B6
NM_000767.5 missense

Scores

3
6
10

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.889

Publications

52 publications found
Variant links:
Genes affected
CYP2B6 (HGNC:2615): (cytochrome P450 family 2 subfamily B member 6) This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010652304).
BP6
Variant 19-41004377-A-G is Benign according to our data. Variant chr19-41004377-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 3033395.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 381 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2B6NM_000767.5 linkc.415A>G p.Lys139Glu missense_variant Exon 3 of 9 ENST00000324071.10 NP_000758.1 P20813-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2B6ENST00000324071.10 linkc.415A>G p.Lys139Glu missense_variant Exon 3 of 9 1 NM_000767.5 ENSP00000324648.2 P20813-1
CYP2B6ENST00000593831.1 linkc.187A>G p.Lys63Glu missense_variant Exon 2 of 5 2 ENSP00000470582.1 M0QZJ2
CYP2B6ENST00000598834.2 linkn.316A>G non_coding_transcript_exon_variant Exon 3 of 10 5 ENSP00000496294.1 A0A2R8YFA4
CYP2B6ENST00000594187.1 linkn.-2A>G upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00251
AC:
381
AN:
152058
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000895
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00454
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00233
AC:
585
AN:
251312
AF XY:
0.00221
show subpopulations
Gnomad AFR exome
AF:
0.000862
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00428
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00398
AC:
5816
AN:
1461828
Hom.:
20
Cov.:
33
AF XY:
0.00379
AC XY:
2757
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.000597
AC:
20
AN:
33474
American (AMR)
AF:
0.00125
AC:
56
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000557
AC:
48
AN:
86240
European-Finnish (FIN)
AF:
0.000506
AC:
27
AN:
53400
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.00496
AC:
5520
AN:
1111998
Other (OTH)
AF:
0.00235
AC:
142
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
347
694
1040
1387
1734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00250
AC:
381
AN:
152176
Hom.:
2
Cov.:
31
AF XY:
0.00207
AC XY:
154
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.000892
AC:
37
AN:
41476
American (AMR)
AF:
0.00150
AC:
23
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4814
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00454
AC:
309
AN:
68006
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00304
Hom.:
1
Bravo
AF:
0.00249
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00701
AC:
27
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00360
AC:
31
ExAC
AF:
0.00228
AC:
277
EpiCase
AF:
0.00338
EpiControl
AF:
0.00350

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CYP2B6: BP4, BS2 -

CYP2B6-related disorder Benign:1
Feb 15, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.71
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.22
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.028
T;T;T
Eigen
Uncertain
0.21
Eigen_PC
Benign
0.063
FATHMM_MKL
Benign
0.24
N
LIST_S2
Uncertain
0.97
.;D;D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Benign
-0.42
T
MutationAssessor
Uncertain
2.8
M;M;.
PhyloP100
0.89
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-3.6
.;D;.
REVEL
Benign
0.29
Sift
Pathogenic
0.0
.;D;.
Sift4G
Pathogenic
0.0010
.;D;D
Polyphen
0.99
D;D;.
Vest4
0.51, 0.65
MVP
0.78
MPC
0.42
ClinPred
0.043
T
GERP RS
3.8
PromoterAI
0.00080
Neutral
Varity_R
0.92
gMVP
0.35
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12721655; hg19: chr19-41510282; COSMIC: COSV107363307; API